End-of-day quote
Other stock markets
|
||
- CAD | - |
15/05 | Transcript : MediPharm Labs Corp., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | MediPharm Labs Q1 Gross Profit, Rise | MT |
Sales 2024 * | 4.38Cr 3.18Cr 265.96Cr | Sales 2025 * | 5.49Cr 3.99Cr 333.3Cr | Capitalization | 3.04Cr 2.21Cr 184.27Cr |
---|---|---|---|---|---|
Net income 2024 * | -80L -58.08L -49Cr | Net income 2025 * | -30L -21.78L -18Cr | EV / Sales 2024 * | 0.69 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-3.75
x | P/E ratio 2025 * |
-7.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.47% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
1st Jan change | Capi. | |
---|---|---|
+41.50% | 620.2Cr | |
-22.89% | 410.15Cr | |
+9.36% | 341.34Cr | |
-19.39% | 282.85Cr | |
-11.05% | 228.73Cr | |
+45.24% | 193.38Cr | |
-7.51% | 152.18Cr | |
+46.81% | 151.47Cr | |
-18.04% | 149.42Cr |